EH Group tests HTPEM Fuel Cell to decarbonise aviation
EH Group has successfully tested its unique fuel cell technology in high temperature PEM mode (HTPEMFC). The proprietary structure of EH Group’s cells enables it to operate as a “platform” technology – its unparalleled design flexibility on form-factor and size means that with relative ease we are able to modify certain materials such as the membrane to run it in LT or HT fuel cell mode. More crucially the performance edge we have achieved in PEMFC appears replicable in HTPEMFC too.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231022026341/en/
EH Group HTPEM Fuel Cell Stack (Photo: Business Wire)
Preliminary testing on short stacks has delivered more than 2.3 kW/L of power at atmospheric pressure thanks to our unique stack structure and design with <1mm cell pitch.
“It is extremely satisfying to see the validation of our cell structure as a platform technology. It opens up a whole new arena of development in HTPEMFC and new application potential,” states Mardit Matian, Founder of EH Group.
High Temperature PEM Fuel Cells offer the potential to decarbonise aviation, for aircraft requiring well beyond the power range of batteries and even LTPEM fuel cells. In addition, they open up other significant market opportunities such as in the maritime sector and stationary power.
“Whilst there is clearly some development work to be undertaken, this technology would be an ideal candidate for the maritime and aviation sectors for example where hydrogen purity & thermal management challenges are more pronounced,” added Christopher Brandon, Co-Founder.
About EH Group
Established in Switzerland since 2017, EH Group is focused on the design and production of its innovative fuel cell technology. It offers unrivalled power density, greater system efficiency and a unique assembly process that radically reduces costs. It is aimed at the decarbonisation of heavy duty mobility such as marine vessels, off-highway vehicles, trucking and aviation as well as large scale stationary power.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forrester: European Retail Sales To Reach €2.7 Trillion By 20286.12.2023 11:00:00 CET | Press release
Forrester (Nasdaq: FORR) forecasts that total retail sales of Europe-5 countries (France, Germany, Italy, Spain, and the UK) will increase from €2.3 trillion in 2023 to reach €2.7 trillion in 2028 at a 2.9% compound annual growth rate (CAGR). Forrester’s recently released report, Europe-5 Online Retail Forecast, 2023 To 2028, estimates total retail sales, online retail sales, and online retail penetration across 22 product categories, including fashion, homeware, food and drink, consumer electronics, and media, for each of the Europe-5 economies. Germany holds the largest share of the retail market among these five countries, followed (in order) by the UK and France. In 2022, offline retail growth outpaced online retail growth for the first time as more consumers shopped in stores, and this momentum continued into 2023, but the fundamental growth drivers of online retail such as greater product selection, round-the-clock availability, and competitive pricing remain strong. As a result,
Kaneka Acquires Japan Medical Device Technology6.12.2023 10:40:00 CET | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has acquired all shares of Japan Medical Device Technology Co., Ltd. (Headquarters: Kamimashiki-gun, Kumamoto; President: Shuzo Yamashita) (hereinafter JMDT), a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned subsidiary. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206372197/en/ Stent before expansion (Photo: Business Wire) Kaneka manufactures and sells endovascular catheters, which are devices used in the treatment of cardiac, peripheral vascular, and cerebrovascular diseases. In particular, stenting*1 for the treatment of coronary artery diseases such as atherosclerosis has a market worth 30 billion yen in Japan, and Kaneka is aiming to expand its business in this area. JMDT has high technological capabilities in the research and development of coronary stents and is one of the lead
CommBox launches Era AI to enable customer service to be intelligently automated and CX costs to be cut by 40%6.12.2023 10:00:00 CET | Press release
Today CommBox, the pioneer in AI-powered customer communications, is launching its new generative AI solution. Designed for medium to large businesses across a range of industries including healthcare, banking, retail, telecommunications and insurance, Era AI is based on a winning combination of both proprietary technology developed by CommBox and commercial large language models. Era AI’s functionality scans enterprise knowledge sources and, in just seconds, provides customers with accurate, highly personalised information through the digital messaging channel of their choice. Era AI delivers customer service automation, reduces costs for organisations, and dramatically increases the speed and accuracy of enquiry handling. It does this all while increasing customer satisfaction, with CommBox customers seeing a 92% customer satisfaction rate on average. Central to this is Era AI’s ability to analyse a brand’s entire resource base, such as support articles, help and knowledge centres, a
New Post Hoc Phase 3 Data Analysis Shows AJOVY ® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity6.12.2023 08:00:00 CET | Press release
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announces that a post hoc analysis4 of two phase 3 clinical studies presented today at the European Headache Congress has shown the effectiveness of the migraine prevention treatment AJOVY®(fremanezumab) in reducing migraine attacks in patients with migraine and co-morbid obesity. Migraine and obesity are both associated with high levels of disability3 and both conditions are more prevalent amongst females5,6. It is estimated that 59% of people in Europe are either overweight or obese, with almost a quarter (23%) of adults living with obesity5. A higher body mass index (BMI) is frequently associated with increased migraine prevalence and severity, and an increased number of adverse effects3. As such, assessing the efficacy and safety of migraine preventative treatment in patients with obesity can help guide migraine management and treatment decisions. The post hoc analysis of the HALO-LTS1 and FOCUS2 phase 3 studies compared the
Splashtop Wins the SDC "Security Vendor of The Year” Award6.12.2023 07:30:00 CET | Press release
Splashtop, a pioneer in transforming the work-anywhere landscape, proudly emerges as the "Security Vendor of the Year" at the 14th edition of the SDC Awards, hosted in London. This prestigious award highlights Splashtop's commitment to protecting organizations of any size with enterprise-grade encryption and permission-based access. Since its inception in 2006, Splashtop has consistently delivered cutting-edge remote access and support technology, empowering users to access devices, apps, and documents from anywhere, without compromising performance. In 2023, the company has taken a significant leap forward, addressing the modern challenges of remote workforces, multi-cloud migration, complex network access, and credential management—even for those with limited IT resources. This year Splashtop has expanded its security portfolio with groundbreaking solutions for Endpoint Security, Wi-Fi and Server Access control, and the innovative Splashtop Secure Workspace. These solutions address t